Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Quentin30on Dec 30, 2024 2:37pm
368 Views
Post# 36381254

RE:RE:RE:Next price target

RE:RE:RE:Next price targetYes Canadafan, all markets are down... great observation, so if we compare ONCY to market performance over the past, 5, 10, 15, 20, 25 years, then how well is ONCY doing in comparison ?

If ONC is bought out for 100 million... would that be enough of premium to tempt you to sell... The longer ONCY waits to secure a partner, the less capital reserves they have, and these are due to run dry by the end of Q2.

ONC.TO is down 31% over the past year
Nasdaq is up 27% over the past year
ONC.TO is down 76% over the past 5 years
Nasdaq up 144% over the past 5 years
ONC.TO is down 99% since listing in 2000
Nasdaq is up over 3000% since 01 Jul 2000

yup... when you compare against the markets, ONCY looks like a real winner doesn't it...  LOL
<< Previous
Bullboard Posts
Next >>